I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Effects of Dapagliflozin on Body Composition and Liver Test..:
Hiroshi Tobita, MD, PhD
;
Shuichi Sato, MD, PhD
;
Tatsuya Miyake, MD, PhD
..
http://www.sciencedirect.com/science/article/pii/S0011393X17300061. , 2017
Link:
https://doi.org/10.1016/j.curtheres.2017.07.002
RT Journal T1
Effects of Dapagliflozin on Body Composition and Liver Tests in Patients with Nonalcoholic Steatohepatitis Associated with Type 2 Diabetes Mellitus: A Prospective, Open-label, Uncontrolled Study
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:6fcc446b51304049bb4439d7fbb812a7&Exemplar=1&LAN=DE A1 Hiroshi Tobita, MD, PhD A1 Shuichi Sato, MD, PhD A1 Tatsuya Miyake, MD, PhD A1 Shunji Ishihara, MD, PhD A1 Yoshikazu Kinoshita, MD, PhD PB Elsevier YR 2017 K1 nonalcoholic K1 steatohepatitis K1 type 2 diabetes mellitus K1 sodium–glucose K1 cotransporter 2-inhibitor K1 dapagliflozin K1 open-label K1 Therapeutics. Pharmacology K1 RM1-950 JF http://www.sciencedirect.com/science/article/pii/S0011393X17300061 LK http://dx.doi.org/https://doi.org/10.1016/j.curtheres.2017.07.002 DO https://doi.org/10.1016/j.curtheres.2017.07.002 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)